Suppr超能文献

胃癌的p53基因多态性:早期胃癌与进展期胃癌的差异

A p53 genetic polymorphism of gastric cancer: difference between early gastric cancer and advanced gastric cancer.

作者信息

Yi Sun Young, Lee Woon Jung

机构信息

Department of Internal Medicine and Medical Research Center, College of Medicine, Ewha Womans University, Seoul, Korea.

出版信息

World J Gastroenterol. 2006 Oct 28;12(40):6536-9. doi: 10.3748/wjg.v12.i40.6536.

Abstract

AIM

To investigate the role of the polymorphism of p53 codon 72 in early gastric cancer (EGC) and advanced gastric cancer (AGC) in Korean patients.

METHODS

DNA was extracted from blood samples of gastric cancer patients (n=291) and controls (n=216). In the p53 codon 72 genotypes were determined by PCR-RFLP.

RESULTS

Patients with gastric cancer had a significantly higher frequency of the homozygous proline (Pro) allele than the control (P=0.032). Patients with AGC had a significantly higher frequency of the Arg/Arg (arginine) allele (P=0.038) than EGC and a similar Pro/Pro allele. The signet ring cell type had a higher frequency of the Pro/Pro allele than other types (P=0.031). The Pro/Pro genotype carries a 3.9-fold increased risk of developing gastric cancer (95% CI, 1.3-15.4, P=0.039) when compared to Arg/Arg and Arg/Pro genotypes and to develop EGC is a 5.25 fold increased risk (95% CI, 1.8-19.6, P=0.021).

CONCLUSION

The Pro/Pro genotype of the p53 codon 72 polymorphism carries a higher risk for gastric cancer in general and is also associated with a much higher risk for EGC than AGC.

摘要

目的

研究p53密码子72多态性在韩国早期胃癌(EGC)和进展期胃癌(AGC)患者中的作用。

方法

从胃癌患者(n = 291)和对照组(n = 216)的血液样本中提取DNA。通过PCR-RFLP确定p53密码子72的基因型。

结果

胃癌患者中纯合脯氨酸(Pro)等位基因的频率显著高于对照组(P = 0.032)。AGC患者中Arg/Arg(精氨酸)等位基因的频率(P = 0.038)显著高于EGC患者,且Pro/Pro等位基因频率相似。印戒细胞型Pro/Pro等位基因的频率高于其他类型(P = 0.031)。与Arg/Arg和Arg/Pro基因型相比,Pro/Pro基因型患胃癌的风险增加3.9倍(95%CI,1.3 - 15.4,P = 0.039),患EGC的风险增加5.25倍(95%CI,1.8 - 19.6,P = 0.021)。

结论

p53密码子72多态性的Pro/Pro基因型总体上患胃癌的风险更高,且与EGC的风险关联程度远高于AGC。

相似文献

1
A p53 genetic polymorphism of gastric cancer: difference between early gastric cancer and advanced gastric cancer.
World J Gastroenterol. 2006 Oct 28;12(40):6536-9. doi: 10.3748/wjg.v12.i40.6536.
3
P53 genetic polymorphism of gastric cancer in Korea.
Korean J Intern Med. 2006 Mar;21(1):28-32. doi: 10.3904/kjim.2006.21.1.28.
4
p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population.
Gastric Cancer. 2011 Aug;14(3):242-8. doi: 10.1007/s10120-011-0034-4. Epub 2011 Apr 2.
7
Role of p53 codon 72 polymorphism in the risk of development of distal gastric cancer.
Scand J Gastroenterol. 2005 Jan;40(1):56-60. doi: 10.1080/00365520410009456.
9
P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature.
Int J Cancer. 2007 Oct 1;121(7):1481-6. doi: 10.1002/ijc.22833.

引用本文的文献

2
Systematic Review and Meta-analysis of TP53, HER2/ERBB2, KRAS, APC, and PIK3CA Genes Expression Pattern in Gastric Cancer.
Middle East J Dig Dis. 2022 Jul;14(3):335-345. doi: 10.34172/mejdd.2022.292. Epub 2022 Jul 30.
3
in Human Stomach: The Inconsistencies in Clinical Outcomes and the Probable Causes.
Front Microbiol. 2021 Aug 17;12:713955. doi: 10.3389/fmicb.2021.713955. eCollection 2021.
4
Ewing Sarcoma: influence of TP53 Arg72Pro and MDM2 T309G SNPs.
Mol Biol Rep. 2013 Aug;40(8):4929-34. doi: 10.1007/s11033-013-2593-4. Epub 2013 May 10.
5
Alterations of the TP53 gene in gastric and esophageal carcinogenesis.
J Biomed Biotechnol. 2012;2012:891961. doi: 10.1155/2012/891961. Epub 2012 Aug 7.
6
Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer.
Mol Genet Genomics. 2012 Sep;287(9):755-64. doi: 10.1007/s00438-012-0715-7. Epub 2012 Aug 18.
7
An updated meta-analysis of the p53 codon 72 polymorphism and gastric cancer risk.
Mol Biol Rep. 2012 Aug;39(8):8265-75. doi: 10.1007/s11033-012-1674-0. Epub 2012 Jun 16.
8
TP53 gene polymorphism: importance to cancer, ethnicity and birth weight in a Brazilian cohort.
J Biosci. 2011 Dec;36(5):823-31. doi: 10.1007/s12038-011-9147-5.
10
p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population.
Gastric Cancer. 2011 Aug;14(3):242-8. doi: 10.1007/s10120-011-0034-4. Epub 2011 Apr 2.

本文引用的文献

1
Role of p53 codon 72 polymorphism in the risk of development of distal gastric cancer.
Scand J Gastroenterol. 2005 Jan;40(1):56-60. doi: 10.1080/00365520410009456.
2
p53 mutants: the achilles' heel of human cancers?
Cell Cycle. 2004 Aug;3(8):1030-4. Epub 2004 Aug 7.
6
Molecular mechanisms of H. pylori associated gastric carcinogenesis.
World J Gastroenterol. 1999 Oct;5(5):369-374. doi: 10.3748/wjg.v5.i5.369.
7
8
Alterations in exon 4 of the p53 gene in gastric carcinoma.
Gastroenterology. 2000 Jun;118(6):1039-44. doi: 10.1016/s0016-5085(00)70356-8.
9
A common polymorphism acts as an intragenic modifier of mutant p53 behaviour.
Nat Genet. 2000 May;25(1):47-54. doi: 10.1038/75586.
10
Molecular epidemiology, pathogenesis and prevention of gastric cancer.
Carcinogenesis. 1999 Dec;20(12):2195-208. doi: 10.1093/carcin/20.12.2195.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验